These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 10398977

  • 1. Contrast-enhanced MR imaging of two superparamagnetic RES-contrast agents: functional assessment of experimental radiation-induced liver injury.
    Stiskal M, Demsar F, Mühler A, Schwickert HC, Roberts TP, Szolar D, Fischer H, Brasch RC.
    J Magn Reson Imaging; 1999 Jul; 10(1):52-6. PubMed ID: 10398977
    [Abstract] [Full Text] [Related]

  • 2. Contrast enhancement in experimental radiation-induced liver injury: comparison of hepatocellular and reticuloendothelial particulate contrast agents.
    Stiskal M, Schwickert HC, Demsar F, Roberts TP, Szolar D, Weissleder R, Brasch RC.
    J Magn Reson Imaging; 1996 Jul; 6(2):286-90. PubMed ID: 9132091
    [Abstract] [Full Text] [Related]

  • 3. Early detection of radiation-induced liver injury in rat by superparamagnetic iron oxide-enhanced MR imaging.
    Morimoto N, Ebara M, Kato H, Obata T, Fujita J, Kondo F, Tsujii H, Saisho H.
    J Magn Reson Imaging; 1999 Apr; 9(4):573-8. PubMed ID: 10232517
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents.
    Clément O, Mühler A, Vexler VS, Rosenau W, Berthezène Y, Kuwatsuru R, Brasch RC.
    Radiology; 1992 Oct; 185(1):163-8. PubMed ID: 1523301
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C, Allkemper T, Baermig J, Reimer P.
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [Abstract] [Full Text] [Related]

  • 8. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents.
    Kuwatsuru R, Brasch RC, Mühler A, Mathur A, Vexler VS, Rosenau W, Mintorovitch J, Berthezene Y, Cohen F, Shames DM.
    Radiology; 1997 Jan; 202(1):131-8. PubMed ID: 8988202
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters.
    Tanimoto A, Mukai M, Kuribayashi S.
    Magn Reson Med Sci; 2006 Jul; 5(2):89-98. PubMed ID: 17008765
    [Abstract] [Full Text] [Related]

  • 10. Assessment of early radiation effects on the liver. Comparison of SPECT and MR.
    Masui T, Yan H, Kosugi I, Sakamoto S, Nishimura T, Takahashi M, Kaneko M, Fritz-Zieroth B.
    Acta Radiol; 1996 Sep; 37(5):665-71. PubMed ID: 8915272
    [Abstract] [Full Text] [Related]

  • 11. Monitoring radiation-induced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI.
    Daldrup HE, Link TM, Blasius S, Strozyk A, Könemann S, Jürgens H, Rummeny EJ.
    J Magn Reson Imaging; 1999 May; 9(5):643-52. PubMed ID: 10331759
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of the tolerance dose of the hepatic reticulo-endothelial system (RES) after single fraction HDR-irradiation: an in-vivo study employing SSPIO.
    Pech M, Ricke J, Seidensticker M, Staskiewicz G, Wieners G, Mohnike K, Ruhl R, Steinberg J, Wust P, Seidensticker P.
    Int J Radiat Biol; 2008 Oct; 84(10):830-7. PubMed ID: 18979318
    [Abstract] [Full Text] [Related]

  • 14. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R.
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
    Tanimoto A, Kuribayashi S.
    Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230
    [Abstract] [Full Text] [Related]

  • 17. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S, Edelman RR, Sharma P, Li W, Mayo-Smith W, Slater GJ, Eisenberg PJ, Hahn PF.
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver.
    Tanimoto A, Kuribayashi S.
    Magn Reson Med Sci; 2005 May; 4(2):53-60. PubMed ID: 16340158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.